Rockefeller Capital Management »

Neurogene shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.3k 231 31.45

More positions owned by Rockefeller Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tidal Trust Iii Rock Gl Equi Etf (RGEF)
Tidal Trust Iii Rock Us Smal Etf (RSMC)

View all positions for Rockefeller Capital Management

Top funds holding Neurogene

Samsara BioCapital
Casdin Capital
Redmile Group
Rtw Investments
EcoR1 Capital
BlackRock
Baker Bros. Advisors
Balyasny Asset Management
Trails Edge Capital Partners
Toronto-Dominion Bank
Vanguard Capital Management
Jennison Associates
Citadel Advisors
Dr. Jeffrey R. Jay, M.D.
Arrowpoint Asset Management

View all funds holding Neurogene